Cowen And Company, LLC Agios Pharmaceuticals, Inc. Transaction History

Cowen And Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$17.06 - $31.42 $108,876 - $200,522	6,382 Added 30.76%	27,132 $602,000
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $553,610 - $722,307	20,750 New	20,750 $604,000
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $153,049 - $212,415	-3,651 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$52.06 - $61.27 $1.26 Million - $1.48 Million	-24,201 Reduced 86.89%	3,651 $201,000
Q3 2019 Nov 12, 2019	BUY	$32.4 - $49.58 $902,404 - $1.38 Million	27,852 New	27,852 $902,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.